Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin`s lymphoma: combined data from 4 clinical trials - Wiseman, GA; Kornmehl, E; Leigh, B (J Nucl Med, 2003)